GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Marksans Pharma Ltd

Marksans Pharma Board Approves Unaudited Q2 FY27 Results

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 04 Nov 2026, 01:27 PM IST  ·  BSE ID: 47f93c3a-4270-4c89-bbde-1941323c76df
View Original BSE Filing (PDF)
💡
In Simple Terms
Marksans Pharma's board reviewed and approved the latest financial report for the quarter and half-year ending September 30, 2026.
🤖 AI Summary
  • Marksans Pharma's Board approved unaudited financial results for Q2 FY27 and H1 FY27.
  • The meeting was held on November 4, 2026, concluding at 01:20 p.m.
  • Statutory auditors issued an unmodified limited review report on the results.
  • Financial results are available on the company website and BSE filings.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time. Shareholders should refer to the company website for the detailed financial results.
👤
Who Is Affected
All shareholders are affected as the Board has reviewed and approved the latest financial performance disclosures.
🔍
Management Signal
Management is adhering to regulatory timelines for financial reporting and auditor review processes.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Detailed Q2 FY27 financial results disclosure
H1 FY27 consolidated financial statements
Management commentary on the latest financial performance
LOW RISK Routine board meeting outcome for results approval; no new material risks identified in this filing.
💡 Investor Takeaway
Marksans Pharma's Board of Directors approved the unaudited financial results for the quarter and half-year ended September 30, 2026. The company's statutory auditors provided an unmodified opinion on these results.
❓ Frequently Asked Questions
What was decided at the Marksans Pharma Board meeting on November 4, 2026?
The Board of Directors approved the unaudited financial results for the quarter and half-year ended September 30, 2026, along with the limited review reports.
Did the auditors provide an opinion on Marksans Pharma's Q2 FY27 results?
Yes, MSKA & Associates LLP, the statutory auditors, submitted a limited review report with an unmodified opinion on the results.
Where can I find the detailed financial results of Marksans Pharma?
The detailed financial results are available on the company's website at http://www.marksanspharma.com/quarterly-results.html.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.